AbbVie
ABBV
₹15,884
Share price
3.22%
Change (1 day)
13.58%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
AbbVie (ABBV) - Net assets
Net assets on the balance sheet as of December 2024 : ₹287.00 Billion
According to AbbVie's latest financial reports the company has ₹287.00 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
AbbVie - Net assets on balance sheet (from 2011 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $₹288.58 B | -66.66% |
| 2023-12-31 | $₹865.53 B | -39.49% |
| 2022-12-31 | $₹1.430 T | 24.51% |
| 2021-12-31 | $₹1.148 T | 19.95% |
| 2020-12-31 | $₹957.83 B | -264.36% |
| 2019-12-31 | $-₹582.76 Billion | -1.32% |
| 2018-12-31 | $-₹590.57 Billion | -281.46% |
| 2017-12-31 | $₹325.44 B | 3.3% |
| 2016-12-31 | $₹315.03 B | 20.17% |
| 2015-12-31 | $₹262.16 B | 137.46% |
| 2014-12-31 | $₹110.40 B | -60.22% |
| 2013-12-31 | $₹277.51 B | 50.71% |
| 2012-12-31 | $₹184.13 B | -70.83% |
| 2011-12-31 | $₹631.20 B | -10.3% |
| 2010-12-31 | $₹703.65 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | ₹7.550 T | 2,530.71% | 🇺🇸 USA |
 | ₹1.398 T | 387.16% | 🇺🇸 USA |
 | ₹1.217 T | 324.24% | 🇺🇸 USA |
 | ₹501.41 B | 74.70% | 🇺🇸 USA |
 | ₹1.642 T | 472.12% | 🇺🇸 USA |
 | ₹1.426 T | 396.91% | 🇺🇸 USA |
 | ₹1.401 T | 388.16% | 🇬🇧 UK |
 | ₹3.487 T | 1,114.95% | 🇬🇧 UK |
 | ₹220.94 B | -23.02% | 🇺🇸 USA |